Showing 1 - 10 of 58
security. While numerous experimental and farm-level studies have found that adoption of genetically engineered crops has been … county-level corn yields from 1980 to 2015 in conjunction with data on adoption of genetically engineered crops, weather, and … genetically engineered crops have increased yields above trend. There is marked heterogeneity in the effect of adoption of …
Persistent link: https://www.econbiz.de/10012455163
Profit on proprietary research tools is determined partly by the remedies for infringement, such as damages and injunctions. We investigate how damages under a liability rule and the opportunity for injunctions under a property rule can affect the incentives to develop research tools. We show...
Persistent link: https://www.econbiz.de/10012471710
We empirically assess the potential financial impact of future gene therapies on the US economy. After identifying 109 late-stage gene therapy clinical trials currently underway, we estimate the number of new and existing patients with corresponding diseases to be treated by these gene...
Persistent link: https://www.econbiz.de/10012510507
The unavailability of potential stem cell donors poses a critical challenge for donor registries worldwide. This study investigates the impact of initiatives of a stem cell donor registry to enhance donors' availability for confirmatory typing. Initiatives ask donors to provide a sample for...
Persistent link: https://www.econbiz.de/10013172156
temporal variation in the adoption of GE crops to identify the average yield effect due to GE technologies among adopters. The …. Genetically engineered crops appear to play an important role in arbitrating tensions between energy production, environmental …
Persistent link: https://www.econbiz.de/10012461958
Do intellectual property (IP) rights on existing technologies hinder subsequent innovation? Using newly-collected data on the sequencing of the human genome by the public Human Genome Project and the private firm Celera, this paper estimates the impact of Celera's gene-level IP on subsequent...
Persistent link: https://www.econbiz.de/10012462442
Individual, personalized genetic information is increasingly available, leading to the possibility of greater adverse selection over time, particularly in individual-payer insurance markets; this selection could impact the viability of these markets. We use data on individuals at risk for...
Persistent link: https://www.econbiz.de/10012463324
This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...
Persistent link: https://www.econbiz.de/10012466796
Biologics accounted for roughly $145 billion in spending in 2018 (IQVIA, 2019). They are also the fastest growing segment of the pharmaceutical industry. The Biological Price Competition and Innovation Act (BPCIA) of 2010 created an abbreviated pathway for biosimilar products to promote price...
Persistent link: https://www.econbiz.de/10012496071
Pharmacogenomics, or the application of genetic testing to guide drug selection and/or dosing, is often cited as integral to the vision of how precision medicine can be integrated into routine clinical practice. Yet despite a growing base of scientific discovery on genetic variation that...
Persistent link: https://www.econbiz.de/10012453580